These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31498988)

  • 1. Limitations of Ligand-Only Approaches for Predicting the Reactivity of Covalent Inhibitors.
    Voice A; Tresadern G; van Vlijmen H; Mulholland A
    J Chem Inf Model; 2019 Oct; 59(10):4220-4227. PubMed ID: 31498988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the Armory: Predicting and Tuning Covalent Warhead Reactivity.
    Lonsdale R; Burgess J; Colclough N; Davies NL; Lenz EM; Orton AL; Ward RA
    J Chem Inf Model; 2017 Dec; 57(12):3124-3137. PubMed ID: 29131621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How accurate is the description of ligand-protein interactions by a hybrid QM/MM approach?
    Kollar J; Frecer V
    J Mol Model; 2017 Dec; 24(1):11. PubMed ID: 29234892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Study of the Glutathione Reactivity of
    Birkholz A; Kopecky DJ; Volak LP; Bartberger MD; Chen Y; Tegley CM; Arvedson T; McCarter JD; Fotsch C; Cee VJ
    J Med Chem; 2020 Oct; 63(20):11602-11614. PubMed ID: 32965113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Fast Ab Initio Predictor Tool for Covalent Reactivity Estimation of Acrylamides.
    Palazzesi F; Grundl MA; Pautsch A; Weber A; Tautermann CS
    J Chem Inf Model; 2019 Aug; 59(8):3565-3571. PubMed ID: 31246457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Label-Free Bottom-Up Proteomic Workflow for Simultaneously Assessing the Target Specificity of Covalent Drug Candidates and Their Off-Target Reactivity to Selected Proteins.
    Yang Y; Shu YZ; Humphreys WG
    Chem Res Toxicol; 2016 Jan; 29(1):109-16. PubMed ID: 26675335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitors.
    Flanagan ME; Abramite JA; Anderson DP; Aulabaugh A; Dahal UP; Gilbert AM; Li C; Montgomery J; Oppenheimer SR; Ryder T; Schuff BP; Uccello DP; Walker GS; Wu Y; Brown MF; Chen JM; Hayward MM; Noe MC; Obach RS; Philippe L; Shanmugasundaram V; Shapiro MJ; Starr J; Stroh J; Che Y
    J Med Chem; 2014 Dec; 57(23):10072-9. PubMed ID: 25375838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.
    Gehringer M; Laufer SA
    J Med Chem; 2019 Jun; 62(12):5673-5724. PubMed ID: 30565923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance.
    Schwartz PA; Kuzmic P; Solowiej J; Bergqvist S; Bolanos B; Almaden C; Nagata A; Ryan K; Feng J; Dalvie D; Kath JC; Xu M; Wani R; Murray BW
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):173-8. PubMed ID: 24347635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Michael-acceptor reactivity and toxicity through quantum chemical transition-state calculations.
    Mulliner D; Wondrousch D; Schüürmann G
    Org Biomol Chem; 2011 Dec; 9(24):8400-12. PubMed ID: 22048735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships for reactivity of carbonyl-containing compounds with glutathione.
    Schultz TW; Yarbrough JW; Johnson EL
    SAR QSAR Environ Res; 2005 Aug; 16(4):313-22. PubMed ID: 16234173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors.
    Scarpino A; Petri L; Knez D; Imre T; Ábrányi-Balogh P; Ferenczy GG; Gobec S; Keserű GM
    J Comput Aided Mol Des; 2021 Feb; 35(2):223-244. PubMed ID: 33458809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Study of the Glutathione (GSH) Reactivity of N-Arylacrylamides: 1. Effects of Aryl Substitution.
    Cee VJ; Volak LP; Chen Y; Bartberger MD; Tegley C; Arvedson T; McCarter J; Tasker AS; Fotsch C
    J Med Chem; 2015 Dec; 58(23):9171-8. PubMed ID: 26580091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative reactivity analysis of small-molecule thiol surrogates.
    Petri L; Ábrányi-Balogh P; Varga PR; Imre T; Keserű GM
    Bioorg Med Chem; 2020 Apr; 28(7):115357. PubMed ID: 32081630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIreactive: A Machine-Learning Model to Estimate Covalent Warhead Reactivity.
    Palazzesi F; Hermann MR; Grundl MA; Pautsch A; Seeliger D; Tautermann CS; Weber A
    J Chem Inf Model; 2020 Jun; 60(6):2915-2923. PubMed ID: 32250627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parameterization of a B3LYP specific correction for non-covalent interactions and basis set superposition error on a gigantic dataset of CCSD(T) quality non-covalent interaction energies.
    Schneebeli ST; Bochevarov AD; Friesner RA
    J Chem Theory Comput; 2011 Mar; 7(3):658-668. PubMed ID: 22058661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Landscape of
    Hasan MN; Ray M; Saha A
    J Phys Chem B; 2023 Nov; 127(45):9663-9684. PubMed ID: 37921534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BIreactive: Expanding the Scope of Reactivity Predictions to Propynamides.
    Hermann MR; Tautermann CS; Sieger P; Grundl MA; Weber A
    Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding Mode Prediction and Virtual Screening Applications by Covalent Docking.
    Scarpino A; Ferenczy GG; Keserű GM
    Methods Mol Biol; 2021; 2266():73-88. PubMed ID: 33759121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.